Skip to content Skip to footer
Aflibercept-Jbvf: Benefits, Reviews, Info, Side Effects!
Rx Details
Aflibercept-Jbvf
Ziv-aflibercept, Eylea, VEGF Trap
Aflibercept
Prescription
Biologic
Drugs
Prescription Only
treatment for certain types of eye diseases, reduces vision loss, slows progression of macular degeneration, improves visual acuity, decreases retinal swelling, inhibits abnormal blood vessel growth
Bleeding In The Eye, Blurred Vision, Cataract Formation, Eye Irritation, Eye Pain, Feeling Of Having Something In The Eye, Floaters In Vision, Headache, Increased Eye Pressure, Increased Tears, Redness In The Eye, Swelling Of The Eye Or Eyelid
Aflibercept-jbvf, marketed under the brand name Eylea, is a medication used primarily for the treatment of various eye conditions, such as wet age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). The dosage of aflibercept can vary depending on the specific condition being treated. For wet AMD, the typical dosage is 2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 3 months, followed by 2 mg every 8 weeks (2 months). For DME and macular edema following RVO, the dosage is usually 2 mg every 4 weeks (monthly). It’s important to note that the exact dosage and frequency should be determined by a healthcare professional based on the individual patient’s condition and response to treatment. Always consult with a healthcare provider for personalized medical advice.
Wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, macular edema following retinal vein occlusion
Generally well-tolerated with common side effects including hypertension, proteinuria, and gastrointestinal issues.
No Interactions Reported
$1,000 – $2,000
$1,500 per dose.

A Synopsis of

Aflibercept-Jbvf

Aflibercept-Jbvf is a medication that is commonly used in the treatment of certain types of cancer, specifically colorectal cancer and certain eye conditions such as macular degeneration. It belongs to a class of drugs known as vascular endothelial growth factor (VEGF) inhibitors, which work by blocking the growth of blood vessels that supply nutrients to tumors or abnormal blood vessels in the eye.

This medication is typically administered through injection into the affected area, either directly into the eye or intravenously for cancer treatment. It is important to follow the dosing schedule recommended by your healthcare provider to ensure the best possible outcomes.

As with any medication, there are potential side effects associated with Aflibercept-Jbvf. These may include nausea, vomiting, diarrhea, high blood pressure, and changes in vision. It is important to discuss any concerns or side effects with your healthcare provider to determine the best course of action.

It is also important to inform your healthcare provider of any other medications or supplements you are taking, as they may interact with Aflibercept-Jbvf. Additionally, it is important to inform your healthcare provider if you are pregnant or planning to become pregnant, as this medication may have potential risks to a developing fetus.

Overall, Aflibercept-Jbvf is a valuable medication in the treatment of certain types of cancer and eye conditions. By working closely with your healthcare provider and following their recommendations, you can help ensure the best possible outcomes while minimizing potential side effects.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN